Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

A new review and policy statement underscore the inaccuracy of sickle cell trait as a cause of death on autopsies.

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Journavx can be taken with ibuprofen for its anti-inflammatory effects. The prescription medication is not in pharmacies yet, but it maybe there by the end of February. Click here to report a typo.

When prescribing opioids for acute pain, physicians should be attentive to a patient’s individual risk factors, according to ...

For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).

See related article at KEY POINTS Opioids prescribed by clinicians can lead to opioid use disorder, opioid misuse, and other opioid-related harms. A single opioid prescription is not without risk and ...

In the second world war, the physician Henry Beecher observed that some of his soldier patients, despite being injured on the ...

The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

SALT LAKE CITY, UTAH / ACCESS Newswire / February 6, 2025 /CenExel, a leading network of clinical research sites, proudly ...

The US FDA has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.